Debiopharm International S.A.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Debiopharm currently seeks to strengthen its pipeline of oncology and anti-infective programs with promising preclinical assets.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Switzerland
Year Founded:
1979
Main Therapeutic Focus:
Lead Product in Development:
xevinapant
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
7